-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, K+jzWfu1/pTOnY9buPJA9JJrT6TSqrF8KlfCaTmXzZhdtArKoKRrj4axD8w3/qS9 bd9R7U9l1Hm6GXan08wCzA== 0000950133-99-001937.txt : 19990519 0000950133-99-001937.hdr.sgml : 19990519 ACCESSION NUMBER: 0000950133-99-001937 CONFORMED SUBMISSION TYPE: 13F-HR/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19980630 FILED AS OF DATE: 19990518 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BB BIOTECH AG CENTRAL INDEX KEY: 0000924223 STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 0000 [0000] STATE OF INCORPORATION: DC FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR/A SEC ACT: SEC FILE NUMBER: 028-06964 FILM NUMBER: 99629274 BUSINESS ADDRESS: STREET 1: C/O BAKER & MCKENZIE STREET 2: 815 CONNECTICUT AVENUE NW CITY: WASHINGTON STATE: DC ZIP: 20006 BUSINESS PHONE: 2028351882 MAIL ADDRESS: STREET 1: C/O BAKER & MCKENZIE STREET 2: 815 CONNECTICUT AVENUE NW CITY: WASHINGTON STATE: DC ZIP: 20006 13F-HR/A 1 FORM 13F 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F Form 13F COVER PAGE Report for Calendar Year or Quarter Ended: June 30, 1998 Check here if Amendment [ X ]; Amendment Number: 1 This Amendment (Check only one.): [ X ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: BB Biotech AG Address: Vordergasse 3 Grafenauweg 4 Zug, Switzerland CH-6301 Form 13F File Number: 28-6964 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Daniel Bugmann Title: SIGNING AUTHORITY ---------------- Phone: (41-41) 724-5959 Signature, Place, and Date of Signing: /s/ DANIEL BUGMANN Zug, Switzerland, 18 May 1999 - -------------------- 2 Report Type (Check only one.): [ ] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [ ] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [XX] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) List of Other Managers Reporting for this Manager: Name Biotech Focus S.A. Biotech Invest S.A. -2- 3 Form 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 2 Form 13F Information Table Entry Total: 14 Form 13F Information Table Value Total:$716,185 (thousands) List of Other Included Managers: Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. No. Name 1 Biotech Focus S.A. 2 Biotech Invest S.A. 4 BB BIOTECH AG 30-JUN-98 FORM 13F INFORMATION TABLE
- ---------------------------------------------------------------------------------------------------------------------- COLUMN 5: ------------------------------------ COLUMN 4: COLUMN 1: COLUMN 2: COLUMN 3: VALUE NAME OF ISSUER TITLE OF CLASS CUSIP (X$1,000) SHRS OR SH/ PUT/ PRN AMT PRN CALL - ---------------------------------------------------------------------------------------------------------------------- Alexion Common Stock 01535110 $ 18,241 1,824,113 SH Pharmaceuticals Inc. - ---------------------------------------------------------------------------------------------------------------------- Ariad Common Stock 04033A10 $ 8,092 2,273,000 SH Pharmaceuticals Inc. - ---------------------------------------------------------------------------------------------------------------------- Aurora Common Stock 05192010 $ 8,358 1,421,500 SH Biosciences, Inc. - ---------------------------------------------------------------------------------------------------------------------- Aviron Common Stock 05376210 $ 82,818 2,655,286 SH - ---------------------------------------------------------------------------------------------------------------------- Biochem Common Stock 09058T10 $ 182,519 6,887,500 SH Pharma, Inc. - ---------------------------------------------------------------------------------------------------------------------- Clinichem Common Stock 18690610 $ 990 172,188 SH Development, Inc. - ---------------------------------------------------------------------------------------------------------------------- CV Common Stock 12666710 $ 16,998 1,969,647 SH Therapeutics, Inc. - ---------------------------------------------------------------------------------------------------------------------- Genzyme Common Stock 37291710 $ 29,777 1,165,000 SH Corporation - ---------------------------------------------------------------------------------------------------------------------- - ---------------------------------------------------------------------------------------- COLUMN 8: COLUMN 6: COLUMN 7: VOTING AUTHORITY INVESTMENT OTHER MANAGERS ----------------------------- COLUMN 1: DISCTRETION NAME OF ISSUER SOLE SHARED NONE - ---------------------------------------------------------------------------------------- Alexion DEFINED 1,824,113 NONE NONE Pharmaceuticals Inc. - ---------------------------------------------------------------------------------------- Ariad DEFINED 2,273,000 NONE NONE Pharmaceuticals Inc. - ---------------------------------------------------------------------------------------- Aurora DEFINED 1,421,500 NONE NONE Biosciences, Inc. - ---------------------------------------------------------------------------------------- Aviron DEFINED 2 2,655,286 NONE NONE - ---------------------------------------------------------------------------------------- Biochem DEFINED 1 6,887,500 NONE NONE Pharma, Inc. - ---------------------------------------------------------------------------------------- Clinichem DEFINED 1 172,188 NONE NONE Development, Inc. - ---------------------------------------------------------------------------------------- CV DEFINED 1,969,647 NONE NONE Therapeutics, Inc. - ---------------------------------------------------------------------------------------- Genzyme DEFINED 1 1,165,000 NONE NONE Corporation - ----------------------------------------------------------------------------------------
5 - ----------------------------------------------------------------------------------------------------------- La Jolla Common Stock 50345910 $ 10,574 3,021,000 SH Pharmaceutical Company - ----------------------------------------------------------------------------------------------------------- MedImmune, Common Stock 58469910 $ 238,167 3,818,000 SH Inc. - ----------------------------------------------------------------------------------------------------------- Sugen, Inc. Common Stock 86504110 $ 8,678 534,000 SH - ----------------------------------------------------------------------------------------------------------- Synsorb Common Stock 87160V10 $ 10,452 2,115,810 SH Biotech, Inc. - ----------------------------------------------------------------------------------------------------------- Transkaryotic Common Stock 89373510 $ 72,396 2,811,500 SH Therapies, Inc. - ----------------------------------------------------------------------------------------------------------- Vertex Common Stock 92532F10 $ 28,125 1,250,000 SH Pharmaceuticals, Inc. - ----------------------------------------------------------------------------------------------------------- COLUMN $ 716,185 TOTALS - -----------------------------------------------------------------------------------------------------------
- --------------------------------------------------------------------------------------------------------------- La Jolla DEFINED 3,021,000 NONE NONE Pharmaceutical Company - --------------------------------------------------------------------------------------------------------------- MedImmune, DEFINED 1 3,818,000 NONE NONE Inc. - --------------------------------------------------------------------------------------------------------------- Sugen, Inc. DEFINED 534,000 NONE NONE - --------------------------------------------------------------------------------------------------------------- Synsorb DEFINED 2,115,810 NONE NONE Biotech, Inc. - --------------------------------------------------------------------------------------------------------------- Transkaryotic DEFINED 2 2,811,500 NONE NONE Therapies, Inc. - --------------------------------------------------------------------------------------------------------------- Vertex DEFINED 2 1,250,000 NONE NONE Pharmaceuticals, Inc. - --------------------------------------------------------------------------------------------------------------- COLUMN TOTALS - ---------------------------------------------------------------------------------------------------------------
-----END PRIVACY-ENHANCED MESSAGE-----